![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/395 | (2006.01) |
A61K 45/06 | (2006.01) | ||
C07K 16/32 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 4234033 |
(13) | Kind of document | T |
(96) | European patent application number | 23172794.2 |
Date of filing the European patent application | 2012-10-11 | |
(97) | Date of publication of the European application | 2023-08-30 |
(45) | Date of publication and mention of the grant of the patent | 2025-01-29 |
(46) | Date of publication of the claims translation | 2025-04-10 |
(30) | Number | Date | Country code |
201161547535 P | 2011-10-14 | US | |
201161567015 P | 2011-12-05 | US | |
201261657669 P | 2012-06-08 | US | |
201261682037 P | 2012-08-10 | US | |
201261694584 P | 2012-08-29 | US |
(72) |
ALAVATTAM, Sreedhara , US
AMLER, Lukas C. , US
BENYUNES, Mark C. , US
CLARK, Emma I. , GB
DE TOLEDO PELIZON, Christina H. , CH
KWONG GLOVER, Zephania W. , US
MITCHELL, Lada , CH
RATNAYAKE, Jayantha , GB
ROSS, Graham A. , GB
WALKER, Ru-Amir , US
|
(73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | HER2 dimerizacijos inhibitoriaus pertuzumabo panaudojimo būdai ir gamybos produktas, į kurio sudėtį jis įeina |
USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INHIBITOR PERTUZUMAB |